TUI AG (TUIT.L)
Thu, Jun 27 2019
LONDON, June 27 Travel firm TUI said it did not expect an additional financial impact from the grounded 737 MAX after the U.S. Federal Aviation Administration said Boeing must address a new risk on the grounded jet before it can return to service.
LONDON, June 3 Travel company TUI's contingency measures to cope with the grounding of Boeing 737 MAX jets were triggered on Monday, sending its shares down more than 4%.
* Clarity on MAXs needed by end of May to avoid further profit hit (Recasts, adds detail, quotes)
LONDON, May 15 Anglo-German tour operator TUI needs clarity over the status of its grounded Boeing 737 MAX planes by the end of May or it will take another hit on profit, the company said on Wednesday.
FRANKFURT TUI remains committed to its Boeing 737 MAX orders despite two fatal crashes that have led to the grounding of the plane worldwide and caused the Anglo-German tour operator to issue a profit warning on Friday. | Video
FRANKFURT/WASHINGTON Anglo-German tour operator TUI became the latest Boeing 737 MAX operator to warn of a hit to its profits as the U.S. planemaker moved to restore confidence in its best-selling model after two fatal crashes that have grounded the planes worldwide. | Video
* Shares fall to all-time low (Adds executive comments on commitment to Boeing, bookings down; updates shares)
Tour operator TUI warned its profit would fall by at least 200 million euros ($225 million) this year after the grounding of Boeing's 737 MAX aircraft, further evidence of the financial impact of two fatal crashes involving the same type of plane.
FRANKFURT/WASHINGTON, March 29 Anglo-German tour operator TUI became the latest Boeing 737 MAX operator to warn of a hit to its profits as the U.S. planemaker moved to restore confidence in its best-selling model after two fatal crashes that have grounded the planes worldwide.
March 29 Britain's FTSE 100 thrived as hopes of progress in the latest round of Sino-U.S. trade talks ignited optimism, while tour operator TUI tumbled after a profit warning and AstraZeneca weakened after a $6.9 billion cancer drug tie-up.